0001093557-16-000678.txt : 20160909
0001093557-16-000678.hdr.sgml : 20160909
20160909205023
ACCESSION NUMBER: 0001093557-16-000678
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160907
FILED AS OF DATE: 20160909
DATE AS OF CHANGE: 20160909
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DEXCOM INC
CENTRAL INDEX KEY: 0001093557
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330857544
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8582000200
MAIL ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FOLETTA MARK G
CENTRAL INDEX KEY: 0001236389
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51222
FILM NUMBER: 161879836
MAIL ADDRESS:
STREET 1: AMYLIN PHARMACEUTICALS INC
STREET 2: 9360 TOWNE CENTRE DR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2016-09-07
0
0001093557
DEXCOM INC
DXCM
0001236389
FOLETTA MARK G
6340 SEQUENCE DRIVE
SAN DIEGO
CA
92121
1
0
0
0
Common Stock
2016-09-07
4
S
0
1800.0
94.625
D
15643
D
This transaction was executed in multiple trades at prices ranging from $94.60 to $94.68. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Included in this number are 10,027 unvested restricted stock units, 5,450 of which were granted on May 25, 2016 and shall vest on May 25, 2017 and 4,577 of which were granted on November 17, 2014 and shall vest through November 17, 2017.
By: Jess Roper For: Mark G. Foletta
2016-09-09